ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Like this blog? - CLICK "LIKE"

Friday, November 20, 2009

New therapies addresses suffering of MS patients

November 19, 2009

The Multiple Sclerosis Clinic at Toronto's St. Michael's hospital has been treating MS patients for 25 years now, and the prospects for more effective therapies to address both the progress of the disease and their suffering have never looked brighter, says Dr. Paul O'Connor, its director.

"We have made enormous advances in our ability to understand the disease, to diagnose it in early stages and to provide therapies that slow its progress and reduce the frequency of relapses," he says. "We already have at hand five different therapies and I know of at least five more in the pipeline, two of which will be in pill form and will probably be available sometime in the next two years.


"Already we are finding ways to address the disease and have new therapies that, in some patients, seem to improve the quality of life MS can profoundly affect."

Continue from the 4th paragraph: http://www.nationalpost.com/life/health/joint-venture/story.html?id=2242185


============================================

0 comments: